-
Prevention of postoperative recurrence in Crohn’s disease: the never-ending story
- Jung-Bin Park
, Sang Hyoung Park
-
Intest Res. 2022;20(3):279-280.
-
Editorial
Epub July 26, 2022
|
-
Endoscopic diagnosis and treatment of early colorectal cancer
- Seung Wook Hong
, Jeong-Sik Byeon
-
Intest Res. 2022;20(3):281-290.
-
Review
Epub July 26, 2022
|
-
Landscape of inflammatory bowel disease in Singapore
- Daren Low
, Nidhi Swarup , Toshiyuki Okada , et al.
-
Intest Res. 2022;20(3):291-296.
-
Review
Epub January 7, 2022
|
-
Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?
- Ajit Sood
, Ramit Mahajan , Arshdeep Singh , et al.
-
Intest Res. 2022;20(3):297-302.
-
Perspective
Epub February 8, 2022
|
-
Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease
- Anthony Buisson
, Lisa Cannon , Konstantin Umanskiy , et al.
-
Intest Res. 2022;20(3):303-312.
-
Original Article
Epub August 4, 2021
|
-
Risk factors for non-reaching of ileal pouch to the anus in laparoscopic restorative proctocolectomy with handsewn anastomosis for ulcerative colitis
- Shigenobu Emoto
, Keisuke Hata , Hiroaki Nozawa , et al.
-
Intest Res. 2022;20(3):313-320.
-
Original Article
Epub March 12, 2021
|
-
Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease
- Seung Hyuk Kim
, You Sun Kim , Si Hyeong Lee , et al.
-
Intest Res. 2022;20(3):321-328.
-
Original Article
Epub July 20, 2021
|
-
Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
- Shiro Nakamura
, Teita Asano , Hiroaki Tsuchiya , et al.
-
Intest Res. 2022;20(3):329-341.
-
Original Article
Epub August 4, 2021
|
-
A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations
- Dushyant Singh Dahiya
, Asim Kichloo , Farah Wani , et al.
-
Intest Res. 2022;20(3):342-349.
-
Original Article
Epub May 21, 2021
|
-
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
- Seung Yong Shin
, Soo Jung Park , Young Kim , et al.
-
Intest Res. 2022;20(3):350-360.
-
Original Article
Epub July 23, 2021
|
-
Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
- José María Paredes
, Tomás Ripollés , Ángela Algarra , et al.
-
Intest Res. 2022;20(3):361-369.
-
Original Article
Epub March 15, 2022
|
-
Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
- Shigeki Bamba
, Osamu Inatomi , Atsushi Nishida , et al.
-
Intest Res. 2022;20(3):370-380.
-
Original Article
Epub May 14, 2021
|
-
Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis
- Jim O’Connell
, Jayne Doherty , Amy Buckley , et al.
-
Intest Res. 2022;20(3):381-385.
-
Brief Communication
Epub March 11, 2022
|
-
Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
- Yoo Jin Lee
, Seong-Eun Kim , Yong Eun Park , et al.
-
Intest Res. 2022;20(3):386-388.
-
Letter to the Editor
Epub March 11, 2022
|